annual shareholders equity:
$830.44M+$129.53M(+18.48%)Summary
- As of today (September 14, 2025), LGND annual stockholders equity is $830.44 million, with the most recent change of +$129.53 million (+18.48%) on December 31, 2024.
- During the last 3 years, LGND annual shareholders equity has risen by +$9.28 million (+1.13%).
- LGND annual shareholders equity is now at all-time high.
Performance
LGND Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$828.53M+$32.99M(+4.15%)Summary
- As of today (September 14, 2025), LGND quarterly stockholders equity is $828.53 million, with the most recent change of +$32.99 million (+4.15%) on June 30, 2025.
- Over the past year, LGND quarterly shareholders equity has increased by +$53.33 million (+6.88%).
- LGND quarterly shareholders equity is now -23.28% below its all-time high of $1.08 billion, reached on March 31, 2019.
Performance
LGND quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
LGND Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.5% | +6.9% |
| 3 y3 years | +1.1% | +3.3% |
| 5 y5 years | +8.2% | +19.2% |
LGND Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +39.0% | -1.5% | +38.7% |
| 5 y | 5-year | at high | +39.0% | -1.5% | +38.7% |
| alltime | all time | at high | +946.8% | -23.3% | +446.9% |
LGND Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $828.53M(+4.1%) |
| Mar 2025 | - | $795.53M(-4.2%) |
| Dec 2024 | $830.44M(+18.5%) | $830.44M(-1.3%) |
| Sep 2024 | - | $841.18M(+8.5%) |
| Jun 2024 | - | $775.20M(-3.9%) |
| Mar 2024 | - | $806.52M(+15.1%) |
| Dec 2023 | $700.91M(+17.3%) | $700.91M(+4.9%) |
| Sep 2023 | - | $667.90M(+0.5%) |
| Jun 2023 | - | $664.89M(+2.9%) |
| Mar 2023 | - | $646.32M(+8.2%) |
| Dec 2022 | $597.49M(-27.2%) | $597.49M(-26.8%) |
| Sep 2022 | - | $816.30M(+1.7%) |
| Jun 2022 | - | $802.37M(+1.2%) |
| Mar 2022 | - | $793.19M(-3.4%) |
| Dec 2021 | $821.16M(+15.7%) | $821.16M(+1.1%) |
| Sep 2021 | - | $812.07M(+3.2%) |
| Jun 2021 | - | $786.52M(+5.5%) |
| Mar 2021 | - | $745.84M(+5.1%) |
| Dec 2020 | $709.52M(-7.5%) | $709.52M(+1.7%) |
| Sep 2020 | - | $697.82M(+0.4%) |
| Jun 2020 | - | $695.00M(+5.0%) |
| Mar 2020 | - | $661.90M(-13.7%) |
| Dec 2019 | $767.23M(+36.8%) | $767.23M(-9.8%) |
| Sep 2019 | - | $850.58M(-18.3%) |
| Jun 2019 | - | $1.04B(-3.6%) |
| Mar 2019 | - | $1.08B(+92.5%) |
| Dec 2018 | $560.91M(+40.3%) | $560.91M(-19.8%) |
| Sep 2018 | - | $699.52M(+12.9%) |
| Jun 2018 | - | $619.81M(+28.8%) |
| Mar 2018 | - | $481.10M(+20.3%) |
| Dec 2017 | $399.79M(+17.1%) | $399.79M(-0.8%) |
| Sep 2017 | - | $403.17M(+4.7%) |
| Jun 2017 | - | $385.12M(+3.6%) |
| Mar 2017 | - | $371.83M(+8.9%) |
| Dec 2016 | $341.29M(+43.8%) | $341.29M(+0.9%) |
| Sep 2016 | - | $338.25M(+2.6%) |
| Jun 2016 | - | $329.76M(-9.6%) |
| Mar 2016 | - | $364.60M(+53.7%) |
| Dec 2015 | $237.28M(+801.6%) | $237.28M(-18.8%) |
| Sep 2015 | - | $292.18M(+323.1%) |
| Jun 2015 | - | $69.05M(+96.5%) |
| Mar 2015 | - | $35.15M(+33.6%) |
| Dec 2014 | $26.32M(-47.0%) | $26.32M(-40.7%) |
| Sep 2014 | - | $44.37M(-30.9%) |
| Jun 2014 | - | $64.17M(-1.3%) |
| Mar 2014 | - | $65.00M(+31.0%) |
| Dec 2013 | $49.61M(+87.3%) | $49.61M(+10.7%) |
| Sep 2013 | - | $44.81M(+14.1%) |
| Jun 2013 | - | $39.27M(+28.3%) |
| Mar 2013 | - | $30.60M(+15.5%) |
| Dec 2012 | $26.48M(+60.2%) | $26.48M(+24.7%) |
| Sep 2012 | - | $21.23M(+15.1%) |
| Jun 2012 | - | $18.45M(-4.1%) |
| Mar 2012 | - | $19.24M(+16.4%) |
| Dec 2011 | $16.53M(+372.9%) | $16.53M(>+9900.0%) |
| Sep 2011 | - | $0.00(-100.0%) |
| Jun 2011 | - | $14.21M(+2.3%) |
| Mar 2011 | - | $13.89M(+297.6%) |
| Dec 2010 | $3.50M(-71.1%) | $3.50M(-418.9%) |
| Sep 2010 | - | -$1.10M(-110.0%) |
| Jun 2010 | - | $11.00M(+4.9%) |
| Mar 2010 | - | $10.49M(+180.2%) |
| Dec 2009 | $12.09M | $3.74M(-424.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2009 | - | -$1.15M(-70.5%) |
| Jun 2009 | - | -$3.92M(+66.4%) |
| Mar 2009 | - | -$2.35M(-77.3%) |
| Dec 2008 | $1.98M(-95.2%) | -$10.37M(-172.5%) |
| Sep 2008 | - | $14.30M(-54.4%) |
| Jun 2008 | - | $31.37M(-14.9%) |
| Mar 2008 | - | $36.88M(+26.7%) |
| Dec 2007 | $41.46M(+4.4%) | $29.11M(-24.6%) |
| Sep 2007 | - | $38.63M(-17.1%) |
| Jun 2007 | - | $46.58M(-33.2%) |
| Mar 2007 | - | $69.75M(+155.0%) |
| Dec 2006 | $39.70M(-140.5%) | $27.35M(-111.5%) |
| Sep 2006 | - | -$238.84M(+5.6%) |
| Jun 2006 | - | -$226.16M(+6.7%) |
| Mar 2006 | - | -$212.01M(+92.0%) |
| Dec 2005 | -$98.07M(+55.7%) | -$110.42M(+14.9%) |
| Sep 2005 | - | -$96.07M(+6.7%) |
| Jun 2005 | - | -$90.05M(+10.3%) |
| Mar 2005 | - | -$81.61M(+8.4%) |
| Dec 2004 | -$62.97M(-189.0%) | -$75.32M(-283.9%) |
| Sep 2004 | - | $40.96M(-14.7%) |
| Jun 2004 | - | $48.00M(-20.5%) |
| Mar 2004 | - | $60.37M(-14.6%) |
| Dec 2003 | $70.73M(-4.4%) | $70.73M(+13.0%) |
| Sep 2003 | - | $62.60M(+131.3%) |
| Jun 2003 | - | $27.06M(-28.8%) |
| Mar 2003 | - | $38.02M(-48.6%) |
| Dec 2002 | $74.02M(-227.9%) | $74.02M(-8.2%) |
| Sep 2002 | - | $80.67M(-7.3%) |
| Jun 2002 | - | $87.01M(+180.5%) |
| Mar 2002 | - | $31.02M(-153.6%) |
| Dec 2001 | -$57.88M(+5.0%) | -$57.88M(+10.9%) |
| Sep 2001 | - | -$52.17M(+14.3%) |
| Jun 2001 | - | -$45.63M(+19.4%) |
| Mar 2001 | - | -$38.23M(-30.7%) |
| Dec 2000 | -$55.13M(+115.4%) | -$55.13M(+81.7%) |
| Sep 2000 | - | -$30.34M(+80.5%) |
| Jun 2000 | - | -$16.81M(+33.0%) |
| Mar 2000 | - | -$12.64M(-50.6%) |
| Dec 1999 | -$25.59M(+125.2%) | -$25.59M(-43.1%) |
| Sep 1999 | - | -$44.99M(+48.6%) |
| Jun 1999 | - | -$30.27M(+92.1%) |
| Mar 1999 | - | -$15.76M(+38.7%) |
| Dec 1998 | -$11.36M(-133.1%) | -$11.36M(-255.6%) |
| Sep 1998 | - | $7.30M(-46.8%) |
| Jun 1998 | - | $13.73M(-39.8%) |
| Mar 1998 | - | $22.81M(-33.5%) |
| Dec 1997 | $34.35M(-6.9%) | $34.30M(+113.0%) |
| Sep 1997 | - | $16.10M(-30.3%) |
| Jun 1997 | - | $23.10M(-28.3%) |
| Mar 1997 | - | $32.20M(-6.7%) |
| Dec 1996 | $36.91M(+13.3%) | $34.50M(+305.9%) |
| Sep 1996 | - | $8.50M(-33.1%) |
| Jun 1996 | - | $12.70M(-42.8%) |
| Mar 1996 | - | $22.20M(-21.0%) |
| Dec 1995 | $32.60M(+23.8%) | $28.10M(-14.1%) |
| Sep 1995 | - | $32.70M(+25.3%) |
| Mar 1995 | - | $26.10M(-0.8%) |
| Dec 1994 | $26.34M(-38.7%) | $26.30M(-19.6%) |
| Sep 1994 | - | $32.70M(+14.7%) |
| Jun 1994 | - | $28.50M(-20.6%) |
| Mar 1994 | - | $35.90M |
| Dec 1993 | $42.93M(-25.0%) | - |
| Dec 1992 | $57.25M | - |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual stockholders equity?
- What is the all time high annual shareholders equity for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual shareholders equity year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly shareholders equity year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual stockholders equity?
The current annual shareholders equity of LGND is $830.44M
What is the all time high annual shareholders equity for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual stockholders equity is $830.44M
What is Ligand Pharmaceuticals Incorporated annual shareholders equity year-on-year change?
Over the past year, LGND annual stockholders equity has changed by +$129.53M (+18.48%)
What is Ligand Pharmaceuticals Incorporated quarterly stockholders equity?
The current quarterly shareholders equity of LGND is $828.53M
What is the all time high quarterly shareholders equity for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly stockholders equity is $1.08B
What is Ligand Pharmaceuticals Incorporated quarterly shareholders equity year-on-year change?
Over the past year, LGND quarterly stockholders equity has changed by +$53.33M (+6.88%)